Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

Clinical trial NCT06585462 · RECRUITING

Trial details

NCT number: NCT06585462
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cardiometabolic Disease

Start date: 2024-09-09
Primary completion: 2026-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.